Literature DB >> 9163428

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.

K F Kozarsky1, M H Donahee, A Rigotti, S N Iqbal, E R Edelman, M Krieger.   

Abstract

The risk of atherosclerosis, a leading cause of cardiovascular disease and death, is inversely related to plasma levels of high-density lipoprotein (HDL) cholesterol, although the mechanism of this protective effect is unclear. The class B scavenger receptor, SR-BI, is the first HDL receptor to be well defined at a molecular level and is a mediator of selective cholesterol uptake in vitro. It is expressed most abundantly in steroidogenic tissues, where it is coordinately regulated with steroidogenesis by adrenocorticotropic hormone (ACTH), human chorionic gonadotropin (hCG) and oestrogen, and in the liver, where its expression in rats is suppressed by oestrogen. Here we show that adenovirus-mediated, hepatic overexpression of SR-BI in mice on both sinusoidal and canalicular surfaces of hepatocytes results in the virtual disappearance of plasma HDL and a substantial increase in biliary cholesterol. SR-BI may directly mediate these effects by increasing hepatic HDL cholesterol uptake or by increasing cholesterol secretion into bile, or both. These results indicate that SR-BI may be important in hepatic HDL metabolism, in determining plasma HDL concentrations, and in controlling cholesterol concentrations in bile, and thus may influence the development and progression of atherosclerosis and gallstone disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163428     DOI: 10.1038/387414a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  173 in total

1.  Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice.

Authors:  Hong Feng; Ling Guo; Dan Wang; Haiqing Gao; Guihua Hou; Zhong Zheng; Junting Ai; Oded Foreman; Alan Daugherty; Xiang-An Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

2.  Hepatic hepatocyte nuclear factor 4α is essential for maintaining triglyceride and cholesterol homeostasis.

Authors:  Liya Yin; Huiyan Ma; Xuemei Ge; Peter A Edwards; Yanqiao Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

3.  Cooperation between hepatic cholesteryl ester hydrolase and scavenger receptor BI for hydrolysis of HDL-CE.

Authors:  Quan Yuan; Jinghua Bie; Jing Wang; Siddhartha S Ghosh; Shobha Ghosh
Journal:  J Lipid Res       Date:  2013-08-29       Impact factor: 5.922

Review 4.  Molecular regulation of HDL metabolism and function: implications for novel therapies.

Authors:  Daniel J Rader
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

5.  Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.

Authors:  Manojkumar Valiyaveettil; Niladri Kar; Mohammad Z Ashraf; Tatiana V Byzova; Maria Febbraio; Eugene A Podrez
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

Review 6.  Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation.

Authors:  Bernardo L Trigatti
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

7.  Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease.

Authors:  Rinku Pal; Qingen Ke; German A Pihan; Ayce Yesilaltay; Marsha L Penman; Li Wang; Chandramohan Chitraju; Peter M Kang; Monty Krieger; Olivier Kocher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

8.  Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development.

Authors:  Miranda Van Eck; I Sophie T Bos; Reeni B Hildebrand; Brechje T Van Rij; Theo J C Van Berkel
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  SR-BI (Scavenger Receptor Class B Type 1) Is Critical in Maintaining Normal T-Cell Development and Enhancing Thymic Regeneration.

Authors:  Zhong Zheng; Junting Ai; Ling Guo; Xiang Ye; Subbarao Bondada; Deborah Howatt; Alan Daugherty; Xiang-An Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

10.  Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.

Authors:  Amar Bahadur Singh; Bin Dong; Fredric B Kraemer; Yanyong Xu; Yanqiao Zhang; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.